Korean biotech firm takes second shot at Singapore backdoor listing
Singapore
A SOUTH KOREAN steelmaker controls a firm that makes kimchi lactobacillus (lactic acid bacteria) is trying again to secure a listing for the latter biotech firm by a backdoor route.
Stainless steel manufacturer Kossen, a key shareholder of BiogenicsKorea, has signed an implementation agreement with Epicentre Holdings (the former authorised Apple retailer) and Tardis Capital, said Epicentre's judicial managers (JMs) on Wednesday.
TRENDING NOW
Beyond Nvidia: How Singapore is earning its place in the semiconductor value chain
S-Reits an ‘oasis of calm’ amid global bond yield surge: UOBKH
Deutsche Bank’s private bank seeks experienced wealth teams for deeper push into Asia
Can Bali swop beach capital for global capital without the skyscrapers?